Clinical Trial

Kentucky - Quality Improvement Implementation Lung Cancer Screening (QUILS™) Implementation

Recruiting
View on ClinicalTrials.gov →
Summary
This is an optimization pathway for lung cancer screening programs. Enrolled programs will undergo an audit for elements associated with improved quality and retention of patients in the screening process. A feedback report is delivered to identify priorities for process improvement.
Protocol Amendment History 2 changes
critical Primary endpoint(s) modified 2026-06-23
notable Trial sites expanded: 1 -> 17 locations 2026-06-23
Trial Details
NCT Number NCT07639255
Lead Sponsor Timothy Mullett
Conditions Lung Cancer Screening
Enrollment 330 participants
Start Date 2025-04-01
Primary Completion 2027-06-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-01